News
HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Aurinia Pharmaceuticals, Lowers Price Target to $10
23 Feb 24
News, Price Target, Analyst Ratings
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
22 Feb 24
News, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Lowers Price Target to $13
22 Feb 24
News, Price Target, Analyst Ratings
RBC Capital Maintains Outperform on Aurinia Pharmaceuticals, Lowers Price Target to $8
16 Feb 24
News, Price Target, Analyst Ratings
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
15 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback
15 Feb 24
Biotech, Earnings, News, Guidance, Health Care, Buybacks, Top Stories, Movers, General
Aurinia Pharmaceuticals Q4 2023 GAAP EPS $(0.19) Misses $(0.16) Estimate, Sales $45.10M Beat $44.33M Estimate
15 Feb 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
Earnings Outlook For Aurinia Pharmaceuticals
14 Feb 24
Earnings
What's Going On With Aurinia Pharmaceuticals Stock?
5 Jan 24
News, Small Cap, Movers
Press releases
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program
29 Feb 24
Press Releases
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
15 Feb 24
Press Releases
Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024
5 Feb 24
Press Releases
Kane Biotech Announces Special Meeting of Shareholders
18 Jan 24
Press Releases
Thinking about buying stock in C3.ai, Altimmune, Altria Group, Fusion Pharmaceuticals, or Aurinia Pharmaceuticals?
5 Jan 24
Opinion, Press Releases
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results
5 Jan 24
Press Releases